![(3S) -3- [4- [(2-chloro-5-yodophenyl) methyl] phenoxy] tetrahydrofuran 915095-94-2 Imaj Prezantasyon](http://cdn.globalso.com/jdkhc/3S-3-4-2-chloro-5-iodophenyl-methyl-phenoxy-tetrahydrofuran.jpg)
Deskripsyon
Estrikti molekilè (3S)-3-[4-[(2-chloro-5-iodophenyl)methyl]phenoxy]tetrahydrofuran 915095-94-2 fèt pou montre pwopriyete siperyè, fè li yon kandida atire pou dekouvèt dwòg, ki gen anpil valè. byen nan domèn pharmaceutique.Chimi ak byochimi rechèch.Konpozisyon inik li yo ak pwopriyete diferan fè li yon zouti endispansab pou syantis ak chèchè k ap pouswiv inovasyon ak avansman nan domèn pharmaceutique.
Kòm yon engredyan pharmaceutique, (3S)-3-[4-[(2-chloro-5-iodophenyl)methyl]phenoxy]tetrahydrofuran 915095-94-2 gen potansyèl pou fasilite devlopman nouvo dwòg ak terapi.Pite segondè li yo ak estabilite asire rezilta serye nan tès dwòg ak fòmilasyon, ede kreye pi an sekirite, pi efikas medikaman.
Anplis de sa, adaptabilite nan (3S)-3-[4-[(2-chloro-5-iodophenyl)methyl]phenoxy]tetrahydrofuran 915095-94-2 pwolonje pi lwen pase domèn pharmaceutique la.Konpatibilite li ak yon varyete aplikasyon pou rechèch, ki gen ladan sentèz chimik, rechèch byolojik, ak molekilè D, fè li yon avantaj valab pou rechèch syantifik ak eksperyans.
Chwazi nou
JDK posede enstalasyon pwodiksyon premye klas ak ekipman jesyon kalite, ki asire rezèv ki estab nan entèmedyè API.Ekip pwofesyonèl asire R & D nan pwodwi a.Kont tou de, nou ap chèche pou CMO & CDMO nan mache domestik ak entènasyonal.
![Tofacitinib Entèmedyè (2R, 3R) -2,3-bis [(4-methylbenzoyl) oxy] asid suksinik ak (3R, 4R) - N, 4-dimethyl-1- (phenylmethyl) -3-piperidine amine CAS No 477600 -71-8](http://cdn.globalso.com/jdkhc/2R-3R-23-bis-4-methylbenzoyl-oxy-succinic-acid-and-3R-4R-N-4-dimethyl-1-phenylmethyl-3-piperidine-amine.jpg)
